PCC welcomes new members who meet our eligibility criteria

Why should our company join PCC?

Address challenges in precision oncology through collaboration.

Build relationships with precision oncology network to focus on increasing patient impact.

Contribute to improve patient outcomes through greater awareness and access to comprehensive genomic testing.

Leverage expertise and resources to share insights to address challenges in precision oncology.

Collaborate with independent third parties to address systemic care gaps.

Cost sharing to increase awareness and understanding to improve patient outcomes.

An organization is eligible for PCC membership if the following criteria are met:

  • Is a pharmaceutical or biotechnology organization


  • engages in or supports the discovery, development, research, or testing of interventions and diagnostics related to precision oncology.